Skip To Main Content
Bastien Cabarrou on Muck Rack

Bastien Cabarrou

As seen in: Color Research & Application, Nature, MDPI, European Journal of Cancer, EJSO - European Journal of Surgical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bastien

Contact Bastien, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Terminal T-cell exhaustion predicts tumor control independent of immunotherapy in ovarian cancer

|
By Anna Salvioni, Marie Michelas, Mathilde Del, Clara-Maria Scarlata, Noémie Thebault, Giulia C. Leonardi, Nathalie Van Acker, François-Xavier Frenois, Virginie Feliu, Lise Scandella, Bastien Cabarrou, Carlos Martínez-Gómez, Christel Devaud, Ayman Al Saati, Christine Toulas, Thomas Filleron, Guillaume Bataillon, Jean-Pierre Delord, Maha Ayyoub, Alejandra Martinez Verified, Pierre Vuattoux, Bertille Segier, Myriam Maixent, Sylvie Giuriato, Claire Illac, Sarah Betrian, Charlotte Chollet
| Nature Verified
Abstract T-cell exhaustion is typically studied in the context of immune checkpoint blockade, where proliferation and reinvigoration of exhausted cells drives therapeutic responses. However, terminal exhaustion may also represent a marker of chronic tumor-specific activation, raising the possibility that exhausted T cells reflect ongoing endogenous tumor control.
Open in Who Shared Issue with article?

A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas

|
By Bastien Cabarrou, Julia Gilhodes, Adèle Meola, Guillaume Peyraga
| MDPI
4. Discussion Our study was designed to highlight gene signatures associated with progression-free survival and response to radiotherapy and chemotherapy among patients treated for 1p/19q codeleted ODs. Two of the 68 patients we analyzed had 1p/19q codeleted tumors that were IDH wild-type and would not have been identified under the WHO 2021 classification as ODs. In all likelihood, these two patients actually had diffuse leptomeningeal glioneuronal tumors.
Open in Who Shared Issue with article?

Impact of a comprehensive geriatric assessment on decision‐making in older patients with hematological malignancies

|
By Marie Garric, Sandrine Sourdet, Bastien Cabarrou, Zara Steinmeyer
| Color Research & Application Verified
ORIGINAL ARTICLE Marie Garric Corresponding Author garric.m@chu-toulouse.fr orcid.org/0000-0002-4551-6620 Geriatric Department, Internal Medicine and Oncogeriatry Unit, Centre Hospitalier Universitaire de Toulouse, Toulouse, France Correspondence Marie Garric, Geriatric Department, Internal Medicine and Oncogeriatry Unit, Toulouse University Hospital, Place du Docteur Baylac, TSA 40031, 31059, Toulouse Cedex 9, France.
Open in Who Shared Issue with article?
See all 5 articles